IBDEI07W ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3551,1,4,0)
 ;;=4^197.0
 ;;^UTILITY(U,$J,358.3,3551,1,5,0)
 ;;=5^Mets To Lung
 ;;^UTILITY(U,$J,358.3,3551,2)
 ;;=Mets to Lung^267322
 ;;^UTILITY(U,$J,358.3,3552,0)
 ;;=196.2^^33^281^87
 ;;^UTILITY(U,$J,358.3,3552,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3552,1,4,0)
 ;;=4^196.2
 ;;^UTILITY(U,$J,358.3,3552,1,5,0)
 ;;=5^Mets To Lymph Nodes, Abdominal
 ;;^UTILITY(U,$J,358.3,3552,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,3553,0)
 ;;=196.3^^33^281^88
 ;;^UTILITY(U,$J,358.3,3553,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3553,1,4,0)
 ;;=4^196.3
 ;;^UTILITY(U,$J,358.3,3553,1,5,0)
 ;;=5^Mets To Lymph Nodes, Axillary Or Brachial
 ;;^UTILITY(U,$J,358.3,3553,2)
 ;;=^267317
 ;;^UTILITY(U,$J,358.3,3554,0)
 ;;=196.0^^33^281^89
 ;;^UTILITY(U,$J,358.3,3554,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3554,1,4,0)
 ;;=4^196.0
 ;;^UTILITY(U,$J,358.3,3554,1,5,0)
 ;;=5^Mets To Lymph Nodes, Cervical
 ;;^UTILITY(U,$J,358.3,3554,2)
 ;;=Lymph Nodes^267314
 ;;^UTILITY(U,$J,358.3,3555,0)
 ;;=196.1^^33^281^90
 ;;^UTILITY(U,$J,358.3,3555,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3555,1,4,0)
 ;;=4^196.1
 ;;^UTILITY(U,$J,358.3,3555,1,5,0)
 ;;=5^Mets To Lymph Nodes, Mediastinal 
 ;;^UTILITY(U,$J,358.3,3555,2)
 ;;=Lymph Nodes^267315
 ;;^UTILITY(U,$J,358.3,3556,0)
 ;;=196.8^^33^281^91
 ;;^UTILITY(U,$J,358.3,3556,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3556,1,4,0)
 ;;=4^196.8
 ;;^UTILITY(U,$J,358.3,3556,1,5,0)
 ;;=5^Mets To Lymph Nodes, Multiple Sites
 ;;^UTILITY(U,$J,358.3,3556,2)
 ;;=^267320
 ;;^UTILITY(U,$J,358.3,3557,0)
 ;;=V10.51^^33^281^49
 ;;^UTILITY(U,$J,358.3,3557,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3557,1,4,0)
 ;;=4^V10.51
 ;;^UTILITY(U,$J,358.3,3557,1,5,0)
 ;;=5^H/O Bladder Cancer
 ;;^UTILITY(U,$J,358.3,3557,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,3558,0)
 ;;=V10.3^^33^281^50
 ;;^UTILITY(U,$J,358.3,3558,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3558,1,4,0)
 ;;=4^V10.3
 ;;^UTILITY(U,$J,358.3,3558,1,5,0)
 ;;=5^H/O Breast Cancer
 ;;^UTILITY(U,$J,358.3,3558,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,3559,0)
 ;;=V10.41^^33^281^51
 ;;^UTILITY(U,$J,358.3,3559,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3559,1,4,0)
 ;;=4^V10.41
 ;;^UTILITY(U,$J,358.3,3559,1,5,0)
 ;;=5^H/O Cervical Cancer
 ;;^UTILITY(U,$J,358.3,3559,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,3560,0)
 ;;=V10.05^^33^281^52
 ;;^UTILITY(U,$J,358.3,3560,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3560,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,3560,1,5,0)
 ;;=5^H/O Colon Cancer
 ;;^UTILITY(U,$J,358.3,3560,2)
 ;;=H/O Colon Cancer^295207
 ;;^UTILITY(U,$J,358.3,3561,0)
 ;;=V10.03^^33^281^53
 ;;^UTILITY(U,$J,358.3,3561,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3561,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,3561,1,5,0)
 ;;=5^H/O Esophageal Cancer
 ;;^UTILITY(U,$J,358.3,3561,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,3562,0)
 ;;=V10.60^^33^281^55
 ;;^UTILITY(U,$J,358.3,3562,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3562,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,3562,1,5,0)
 ;;=5^H/O Leukemia
 ;;^UTILITY(U,$J,358.3,3562,2)
 ;;=H/O Leukemia^295231
 ;;^UTILITY(U,$J,358.3,3563,0)
 ;;=V10.11^^33^281^56
 ;;^UTILITY(U,$J,358.3,3563,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3563,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,3563,1,5,0)
 ;;=5^H/O Lung Cancer
 ;;^UTILITY(U,$J,358.3,3563,2)
 ;;=H/O Lung Cancer^295211
 ;;^UTILITY(U,$J,358.3,3564,0)
 ;;=V10.79^^33^281^57
 ;;^UTILITY(U,$J,358.3,3564,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3564,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,3564,1,5,0)
 ;;=5^H/O Lymphoma
 ;;^UTILITY(U,$J,358.3,3564,2)
 ;;=H/O Lymphoma^295238
